Pharming Group (PHGUF) to Release Earnings on Thursday

Pharming Group (OTCMKTS:PHGUF) will likely be issuing its quarterly earnings data on Thursday, March 13th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $76.67 million for the quarter.

Pharming Group Stock Down 12.6 %

Shares of PHGUF stock opened at $0.79 on Wednesday. The stock has a market cap of $530.15 million, a P/E ratio of -39.50 and a beta of 0.91. Pharming Group has a one year low of $0.75 and a one year high of $1.07. The stock has a fifty day moving average price of $0.91 and a 200 day moving average price of $0.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 3.53 and a quick ratio of 2.76.

About Pharming Group

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.